MedPath

Treatment of fever (Humma) with Unani medicine Habb-e-Karanjawa

Phase 3
Conditions
Health Condition 1: R509- Fever, unspecified
Registration Number
CTRI/2021/09/037012
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Participants of either sex in the age group 18 to 60 years

2. History of onset of fever within 24 hr

3. Participants with oral temperature >=100 0F presenting with any of the following symptoms:

Body ache

Headache

Joints pain

Shivering

Chills

Sweating

Palpitation

Skin Flushing

Exclusion Criteria

1. Intake of any antipyretic drugs in the previous 8 hrs.

2. Participant having oral temperature of >= 1040F

3. Known high risk clinical conditions such as pneumonia, sepsis, dengue haemorrhagic fever,meningitis, hepatitis B, etc.

4. Immuno-compromised clinical conditions such as HIV/AIDS, cancer, etc.

5. Known cases of other clinically significant co-morbid conditions (severe hepatic, renal, cardiovascular disorders, etc.) that in the opinion of the investigator could affect the efficacy and safety outcome of the study.

6. Thrombocytopaenia defined as absolute platelet count below 50000/ cu.mm.

7. Known hypersensitivity to study drug or any of its ingredients

8. Pregnant and Lactating females

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath